EP Patent

EP3204015A4 — Compositions and methods for inhibition of hao1 (hydroxyacid oxidase 1 (glycolate oxidase)) gene expression

Assigned to Alnylam Pharmaceuticals Inc · Expires 2018-06-20 · 8y expired

What this patent protects

Patent listed against lumasiran-sodium.

Drugs covered by this patent

Patent Metadata

Patent number
EP3204015A4
Jurisdiction
EP
Classification
—
Expires
2018-06-20
Drug substance claim
No
Drug product claim
No
Assignee
Alnylam Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.